Local HealthScience communications consultancy recognized in 1000 Companies to Inspire Britain report

Last month, Oxford PharmaGenesis, an independent HealthScience communications consultancy headquartered in Oxford, was named as one of the Top 1000 Companies to Inspire Britain in a report published this week by the London Stock Exchange Group.

Welcoming the list, Prime Minister Rt Hon Theresa May MP said, “I want to congratulate all of the 1000 high-growth and innovative companies across the UK featured in this year’s report".

“These companies are the lifeblood of the UK economy,” emphasized Chief Executive Officer of the London Stock Exchange Group, Xavier Rolet KBE.

Companies were selected based on being independent, fast-growing and outperforming their sector. Competition for inclusion in the report was tougher this year than previously. Oxford PharmaGenesis was one of only nine companies in the healthcare and pharmaceuticals sector to be included in the list.

“The recognition of Oxford PharmaGenesis in the top 1000 list is a tremendous endorsement of our innovative HealthScience approach, and the outstanding quality of our work and client service,” commented Dr Richard White, Commercial Director. “The fact that none of our competitors made the list shows that Oxford PharmaGenesis is truly a leading company in our sector.”

“Oxford PharmaGenesis is proud to be one of 1000 Companies to Inspire Britain,” said Dr Chris Winchester, Managing Director. “We are clear that we owe this recognition to all the clients, colleagues and partners who enable our success.”